Published in Bioorg Med Chem Lett on December 30, 2008
5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors. ACS Med Chem Lett (2011) 0.80
A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 29.13
Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci (1993) 2.18
Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron (1991) 1.37
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol (1990) 1.24
AMPA receptor modulators as cognitive enhancers. Curr Opin Pharmacol (2004) 1.15
7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J Pharmacol Exp Ther (1995) 1.01
A centrally active drug that modulates AMPA receptor gated currents. Brain Res (1994) 1.01
Synthesis and antiinflammatory activity of 2,6-bis(1,1-dimethylethyl)phenol derivatives. Farmaco (1993) 1.00
Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels (1993) 0.99
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys. Proc Natl Acad Sci U S A (1995) 0.95
Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. Neuropharmacology (2001) 0.94
Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease? Neurobiol Dis (1998) 0.93
Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices. Neuroreport (1996) 0.91
Synthesis of 3,4-dihydro-2H-1,2,4-benzo-thiadiazine 1,1-dioxide derivatives as potential allosteric modulators of AMPA/kainate receptors. J Med Chem (2002) 0.86
The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology (2004) 0.85
Enantiomeric resolution with a new chiral stationary phase of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide, a cognition-enhancing benzothiadiazine derivative. J Pharm Sci (1995) 0.82
Heteroarylalkanoic acids with possible antiinflammatory activities, III. Arch Pharm (Weinheim) (1985) 0.79
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicity. Proc Natl Acad Sci U S A (1997) 0.79
Studies of enantiomerization of chiral 3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide type compounds. Chirality (2001) 0.78
Modulation of kainate--activated currents by diazoxide and cyclothiazide analogues (IDRA) in cerebellar granule neurons. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.78
Chiral resolution of the enantiomers of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide using high-performance liquid chromatography on cellulose-based chiral stationary phases. J Pharm Biomed Anal (2000) 0.78
Enantiomerization and hydrolysis of (+/-)-7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide by stopped-flow multidimensional high-performance liquid chromatography. J Chromatogr A (2008) 0.77
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 5.15
Click chemistry for drug development and diverse chemical-biology applications. Chem Rev (2013) 2.08
Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues. Chem Rev (2005) 1.85
Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol (2008) 1.78
Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor. J Med Chem (2007) 1.77
(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. Anesthesiology (2014) 1.76
Survival and major neonatal complications in infants born between 22 0/7 and 24 6/7 weeks of gestation (1999-2003). Am J Obstet Gynecol (2006) 1.53
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry (2012) 1.47
Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol. Cardiovasc Drugs Ther (2004) 1.37
An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol (2010) 1.35
The preparation and development of cellular membrane affinity chromatography columns. Nat Protoc (2009) 1.34
Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci (2002) 1.33
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors. Eur J Pharmacol (2012) 1.32
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol (2006) 1.30
Allosteric modifiers of neuronal nicotinic acetylcholine receptors: new methods, new opportunities. Med Res Rev (2007) 1.28
Stereoselective and regiospecific hydroxylation of ketamine and norketamine. Xenobiotica (2012) 1.15
Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol. Chirality (2006) 1.14
Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC). J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.10
Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists. Bioorg Med Chem (2009) 1.09
Enantiomer separation by countercurrent chromatography using cinchona alkaloid derivatives as chiral selectors. Anal Chem (2002) 1.09
Chemistry meets proteomics: the use of chemical tagging reactions for MS-based proteomics. Proteomics (2006) 1.08
Development of immobilized membrane-based affinity columns for use in the online characterization of membrane bound proteins and for targeted affinity isolations. Anal Chim Acta (2005) 1.07
The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening. Anal Biochem (2007) 1.07
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Br J Clin Pharmacol (2012) 1.06
Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol (2010) 1.06
Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician (2010) 1.05
On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the alpha3beta4- and alpha4beta2-nicotinic acetylcholine receptors using immobilized receptor-based liquid chromatographic stationary phases. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.04
Fast spiking interneuron control of seizure propagation in a cortical slice model of focal epilepsy. J Physiol (2012) 1.04
Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells. Cell Signal (2013) 1.02
Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors. Anal Chem (2003) 1.02
GABA(A) receptor beta3 subunit deletion decreases alpha2/3 subunits and IPSC duration. J Neurophysiol (2003) 1.01
Initial synthesis and characterization of an immobilized heat shock protein 90 column for online determination of binding affinities. Anal Biochem (2007) 1.01
Conformational mobility of immobilized alpha3beta2, alpha3beta4, alpha4beta2, and alpha4beta4 nicotinic acetylcholine receptors. Anal Chem (2005) 1.00
G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized beta2-adrenergic receptor. Anal Chem (2004) 1.00
Analyte templating: enhancing the enantioselectivity of chiral selectors upon incorporation into organic polymer environments. Anal Chem (2005) 0.98
GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology (2002) 0.98
Interaction of noncompetitive inhibitors with the alpha3beta2 nicotinic acetylcholine receptor investigated by affinity chromatography and molecular docking. J Med Chem (2007) 0.98
Current chemical tagging strategies for proteome analysis by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.97
Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.97
Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells. Xenobiotica (2012) 0.97
Enantioselective interactions of dextromethorphan and levomethorphan with the alpha 3 beta 4-nicotinic acetylcholine receptor: comparison of chromatographic and functional data. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.96
Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats. Drug Metab Dispos (2004) 0.95
Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability. Anal Chim Acta (2006) 0.95
Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography. J Pharm Biomed Anal (2007) 0.94
Quantifying thiol ligand density of self-assembled monolayers on gold nanoparticles by inductively coupled plasma-mass spectrometry. ACS Nano (2013) 0.94
Initial synthesis and characterization of an alpha7 nicotinic receptor cellular membrane affinity chromatography column: effect of receptor subtype and cell type. Anal Chem (2007) 0.94
A validated liquid chromatography method for the simultaneous determination of vitamins A and E in human plasma. J Pharm Biomed Anal (2007) 0.93
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression. Psychopharmacology (Berl) (2014) 0.93
Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons. Eur J Pharmacol (2004) 0.93
Chiral recognition applications of molecularly imprinted polymers: a critical review. Anal Bioanal Chem (2007) 0.91
Improving fragmentation of poorly fragmenting peptides and phosphopeptides during collision-induced dissociation by malondialdehyde modification of arginine residues. J Mass Spectrom (2007) 0.91
Conformational mobility of immobilized proteins. J Pharm Biomed Anal (2006) 0.91
Concentration levels of zearalenone and its metabolites in urine, muscle tissue, and liver samples of pigs fed with mycotoxin-contaminated oats. J Agric Food Chem (2002) 0.91
Gabapentin and (S)-pregabalin decrease intracellular D-serine concentrations in PC-12 cells. Neurosci Lett (2012) 0.91
Simultaneous determination of hydrophilic amino acid enantiomers in mammalian tissues and physiological fluids applying a fully automated micro-two-dimensional high-performance liquid chromatographic concept. J Chromatogr A (2009) 0.90
Derivatisation of arginine residues with malondialdehyde for the analysis of peptides and protein digests by LC-ESI-MS/MS. J Mass Spectrom (2006) 0.90
Development of reactive thiol-modified monolithic capillaries and in-column surface functionalization by radical addition of a chromatographic ligand for capillary electrochromatography. J Chromatogr A (2004) 0.90
Immobilized receptor- and transporter-based liquid chromatographic phases for on-line pharmacological and biochemical studies: a mini-review. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.90
Metabolic profiling of intracellular metabolites in fermentation broths from beta-lactam antibiotics production by liquid chromatography-tandem mass spectrometry methods. J Chromatogr A (2009) 0.90
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. J Med Chem (2010) 0.90
A case study of acute human chlorpyrifos poisoning: novel aspects on metabolism and toxicokinetics derived from liquid chromatography-tandem mass spectrometry analysis of urine samples. Toxicol Lett (2005) 0.90
What is hydroxynorketamine and what can it bring to neurotherapeutics? Expert Rev Neurother (2014) 0.90
Identification and characterization of estrogen receptor-related receptor alpha and gamma in human glioma and astrocytoma cells. Mol Cell Endocrinol (2009) 0.89
HPLC-electrospray mass spectrometric assay for the determination of (R,R)-fenoterol in rat plasma. J Pharm Biomed Anal (2008) 0.89
Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome. Chirality (2010) 0.88
Multiple receptor liquid chromatographic stationary phases: the co-immobilization of nicotinic receptors, gamma-amino-butyric acid receptors, and N-methyl D-aspartate receptors. Pharm Res (2002) 0.88
Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Biochemistry (2009) 0.88
Absolute quantitation of beta-lactoglobulin by protein liquid chromatography-mass spectrometry and its application to different milk products. Anal Chem (2007) 0.88
Metabolic profiles of the mycotoxin zearalenone and of the growth promoter zeranol in urine, liver, and muscle of heifers. J Agric Food Chem (2002) 0.87
Chemical tagging strategies for mass spectrometry-based phospho-proteomics. Methods Mol Biol (2009) 0.87
Peripheral benzodiazepine receptors in potatoes (Solanum tuberosum). Biochem Biophys Res Commun (2004) 0.86
Uniformly-sized, molecularly imprinted polymers for nicotine by precipitation polymerization. J Chromatogr A (2006) 0.86
Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand. Mol Pharmacol (2012) 0.86
Capillary electrophoresis-laser-induced fluorescence (CE-LIF) assay for measurement of intracellular D-serine and serine racemase activity. Anal Biochem (2011) 0.86
The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor. Biochem Pharmacol (2010) 0.86
Synthesis of 3,4-dihydro-2H-1,2,4-benzo-thiadiazine 1,1-dioxide derivatives as potential allosteric modulators of AMPA/kainate receptors. J Med Chem (2002) 0.86
Peripheral benzodiazepine receptor (PBR) new insight in cell proliferation and cell differentiation review. Curr Clin Pharmacol (2008) 0.86
The development and characterization of protein-based stationary phases for studying drug-protein and protein-protein interactions. J Chromatogr A (2011) 0.86
Enantiomer separations in capillary electrophoresis in the case of equal binding constants of the enantiomers with a chiral selector: commentary on the feasibility of the concept. Anal Chem (2004) 0.86
Improved sexual behavior in male rats treated with a Chinese herbal extract: hormonal and neuronal implications. Asian J Androl (2008) 0.85
Cerebral oxygenation in very low birth weight infants supported with sustained lung inflations after birth. Pediatr Res (2011) 0.85